Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk.
Patricia A. Thompson(National Center for Toxicological Research), Christine B. Ambrosone(Unknown), Rosemary Laughlin, Jo L. Freudenheim(University at Buffalo, State University of New York), James R. Marshall(Roswell Park Comprehensive Cancer Center), Peter G. Shields(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Fred F. Kadlubar(National Center for Toxicological Research), Takuma Nemoto, Saxon Graham(Buffalo State University), J E Vena, Angie Stone
PubMed
May 15, 1998
Cited by 205
Related Papers
Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
|Proceedings of the National Academy of Sciences|2005|2.4k
A Population-Based Study of Genes Previously Implicated in Breast Cancer
|New England Journal of Medicine|2021|862
Metabolic gene polymorphism frequencies in control populations.
|PubMed|2001|847
Type I and II Endometrial Cancers: Have They Different Risk Factors?
|Journal of Clinical Oncology|2013|833